Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Sirona Biochem Corp V.SBM

Alternate Symbol(s):  SRBCF

Sirona Biochem Corp. is a cosmetic ingredient and drug discovery company with proprietary platform developed at its laboratory facility in France. Through its wholly owned subsidiary TFChem S.A.R.L., the Company specializes in stabilizing carbohydrate molecules. The principal activities of the Company include development of cosmetic and pharmaceutical active ingredients. TFChem develops and markets its GlycoMim technology for pharmaceutical and biotechnology comp anies. TFChem’s proprietary chemistry technology can be applied to the development of several pharmaceutical domains such as cancer, diabetes, pain and inflammation and cardio-vascular diseases. Its cosmetic therapeutic area includes skincare-dark spot corrector (Rx & OTC), cell preservation and repair (including keloid and scar therapy), skincare-anti aging/anti-wrinkle and skincare-cellulite treatment. It has developed an active ingredient, TFC-1067 for the treatment of Dyschromia (Dark spots on the skin).


TSXV:SBM - Post by User

Comment by lscfaon Dec 03, 2021 8:02pm
121 Views
Post# 34197345

RE:RE:RE:Wangbang phase 1

RE:RE:RE:Wangbang phase 1Chinese waiting for the patent to expire.....
MirrorWorldMan wrote: Howie has not been able to license the molecule to anyone else for phase testing and Wanbang took eight years to get nowhere with it.   Generics can arise 20 years post patent and we have already lost 8 of those 20 years. On top of that it  years and millions of dollars to establish endpoint trials trials to make it even remotely possible to be used by any sensible doctor that does not want to be sued. So it takes about 7 years on average to do Phase 1-3 trials and we don't even have published  results from WannaBang for phae 1 yet. The SGLT2  is almost worthless now. Howie screwed up with. He must quit and go be a doctor. It is unacceptable to lose such a valuable asset, he would of been fired long ago from any reputable company 


<< Previous
Bullboard Posts
Next >>